Twist Bioscience Expands Flexibility of Clonal Genes for Pharmaceutical, Biotechnology and Industrial Chemical Research
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST) today announced the enhanced Twist Clonal Genes product line with the expansion of preparation quantities, delivery formats, buffer options, and tube and plate options. Customers can now access larger amounts of DNA in the format suitable for their specific research needs.“Leveraging our ability to write DNA at scale, we believe the extension of our clonal genes offers our customers a one-stop shop for their pharmaceutical and biotechnology research and a more robust depth of products to complete their research,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “We remain committed to meeting the increasing needs of the research community, as now, more than ever, synthetic biology tools are needed to identify critical targets and develop new therapeutics to treat COVID-19 and also the many other devastating diseases that did not slow down in the face of the global pandem
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics ResearchBusiness Wire
- Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law FirmGlobeNewswire
- Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT [Yahoo! Finance]Yahoo! Finance
TWST
Earnings
- 11/14/25 - Miss
TWST
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- TWST's page on the SEC website